| 1 |
33749884 | Effects of R-flurbiprofen and the oxygenated metabolites of endocannabinoids in inflammatory pain mice models. | 2021 Apr |
1 |
| 2 |
29326169 | Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site. | 2018 Mar 2 |
1 |
| 3 |
24780080 | Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages. | 2015 Jan |
1 |
| 4 |
26406890 | Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor. | 2015 |
1 |
| 5 |
24102214 | Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition. | 2014 Mar |
1 |
| 6 |
22363560 | Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. | 2012 |
1 |
| 7 |
21489986 | The structural basis of endocannabinoid oxygenation by cyclooxygenase-2. | 2011 Jun 10 |
2 |
| 8 |
21501147 | Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. | 2011 Aug |
1 |
| 9 |
11402053 | Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol. | 2001 Aug 10 |
1 |